Class / Patent application number | Description | Number of patent applications / Date published |
424730000 | Containing or obtained from Hypericum (e.g., St. John's wort, etc.) | 24 |
20080220102 | Solubilsation Products of an Active Ingredient Extract - The invention relates to a solubilizate of a phytoextract, which contains a physiological or pharmaceutical active ingredient, which solubilizate contains about 10% by weight to about 30% by weight of the phytoextract, about 4% by weight to about 35% by weight of water, which can be deionised, demineralised or distilled once or many times, and from about 55% by weight to about 75% by weight of an emulsifier having an HLB-value that ranges between 9-16, based on the solubilizate, which is equal to 100% by weight. | 09-11-2008 |
20080241288 | Method and composition of a carminative herb or natural supplement to decrease the adverse events of orlistat, an oral lipase inhibitor - A medicament to decrease the adverse events of Orlistat, an oral lipase inhibitor, arranged to be taken in combination with Orlistat, comprising: an admixture of carminative herbs and one or more chelating agents to absorb and mechanically agitate non-digested fats. | 10-02-2008 |
20080292733 | Antioxidant and Fe2+ Chelating Properties of Herbal Extracts - The present invention is directed to antioxidative and antiproliferative agents containing North American ginseng (proprietary extract HT1001) alone or in combination with | 11-27-2008 |
20080317883 | METHODS FOR TREATING DEPRESSION - The present invention is a method for the treatment of depression comprising administering to a subject in need thereof a therapeutically effective amount of one or more carbamate compounds of Formula 1 and/or Formula 2 as herein defined and shown below for the treatment of depression. | 12-25-2008 |
20090004301 | Method of treating dyshidrosis(pompholyx) and related dry skin disorders - This invention discloses a method of use for a topical herbal formulation alone or in combination with oral administration of niacin (preferably a flush preparation) to prevent and/or treat dyshidrosis (pompholyx) and related skin diseases. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders. The active ingredients within the formula include a combination of dry, aqueous, acid and alcohol extracts of black walnut hull ( | 01-01-2009 |
20090068296 | COMPOSITION FOR IMPROVED PRODUCTION, HEALTH AND FERTILITY TRAITS - This invention relates to products and methods for improving sensory qualities of meat obtained from livestock. In particular, this invention relates to products and methods for reducing off-odors and off-tastes in meat from uncastrated male pigs (boar taint) or from other livestock fed on pasture. According to the invention, this is obtained by administering a product that contains an inducer of the constitutive androstane receptor (CAR). These include plant products derived from | 03-12-2009 |
20090202664 | Herbal cream or oil for the treatment hemorroids and wounds - This (Patent) protection covers the process for preparing cream for wounds and internal and external hemorrhoids which consists of making herbal-oil extract in three different ways. | 08-13-2009 |
20090285916 | METHODS OF DIAGNOSIS AND TREATMENT OF EQUINE LAMINITIS AND CUSHING'S SYNDROME - The invention provides a method for diagnosing a disorder or disease associated with an imbalance of monoamines in a subject, or of diagnosing susceptibility of the subject to the same, wherein the method comprising (a) providing a sample from a subject to be tested, (b) measuring the levels of dopamine, melatonin and/or serotonin in the sample; and (c) comparing the levels measured in step (b) with levels of dopamine, melatonin and/or serotonin associated with a reference population of subjects, wherein a difference in one or more of the levels measured in step (b) with the levels of dopamine, melatonin and serotonin associated with the reference population of subjects is indicative of a positive diagnosis. The invention further provides a method of prevention or treatment of a disorder or disease associated with an imbalance of monoamines, and kits for the same. | 11-19-2009 |
20090297641 | HERBAL COMPOSITIONS FOR THE TREATMENT OF MUCOSAL LESIONS - The present invention provides therapeutic compositions comprising extracts of the plant species | 12-03-2009 |
20100189823 | Method For Preparing A Hypericum Extract In Neem Oil And A Substance So Obtained - A method for making a | 07-29-2010 |
20100255128 | AVIAN FEED COMPOSITION - The invention herein contemplates an avian feed composition and a method for administering and customizing the feed composition for one or more birds. The feed composition aids in preventing infection and illness including parasitic infestation. | 10-07-2010 |
20100297271 | COMPOSITIONS AND METHODS FOR REDUCING HEPATOTOXICITY ASSOCIATED WITH DRUG ADMINISTRATION - The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when coadministered in effective amounts with a drug or other bioactive agent which typically (in the absence of the salicylate compound) produces significant hepatotoxicity as a secondary indication, will substantially reduce or even eliminate such hepatotoxicity. Favorable therapeutic intervention results from the use of the present invention having the effect of reducing hepatotoxicity associated with the administration of certain drugs and other bioactive agents and in certain instances of allowing the administration of higher doses of a compound which, without the coadministration, would produce hepatotoxicity which limits or even negates the therapeutic value of the compound. | 11-25-2010 |
20110008473 | USE OF HYPERICUM PERFORATUM EXTRACTS IN THE TREATMENT OF NEUROPATHIC PAIN - Disclosed is the use of | 01-13-2011 |
20110200690 | COMPOSITIONS AND METHODS FOR TREATING DEPRESSION - Disclosed are a novel combination of specific therapeutics selected from S-adenosyl methionine or a salt thereof, folic acid or a metabolite or salt thereof, and one or more omega-3 fatty acids or salts thereof, useful for a variety of conditions, as discussed herein. Methods of treatment include the treatment of neuropsychiatric conditions, such as depression. | 08-18-2011 |
20110212193 | Herbal Ointment for Musculoskeletal and Joint-Related Conditions - An herbal ointment. The herbal ointment may include about 45 weight percent of herb-infused oil, water or alcohol, or any desired combination thereof, about 30 weight percent purified water, about 10 weight percent emulsifier wax, about 5 weight percent menthol, about 3 weight percent dimethyl isosorbide, about 2 weight percent glycerin, about 2 weight percent hydrogenated methyl abietate, about 0.5 weight percent | 09-01-2011 |
20120269910 | Method for Testing a Substance Which is Potentially Active in the Field of Lipolysis and its Mainly Cosmetic Use - A method of testing a substance potentially active in the field of lipolysis comprising: preparing a substrate containing at least one triacylglycerol; placing this substrate in contact with a substance potentially active in the field of lipolysis, and with a lipoprotein lipase, in the presence of a cofactor of lipoprotein lipase, for a period of time sufficient to release at least in part one fatty acid of the triacylglycerol; and determining the capacity of inhibition of the release of the fatty acid resulting from the activity of the lipoprotein lipase, under the action of said potentially active substance, and evaluating the result of the inhibition which is either compared to the result obtained in the absence of the potentially active substance tested or compared with the result obtained in the presence of a known inhibitor acting as reference. Cosmetic and pharmaceutical uses are described. | 10-25-2012 |
20120328719 | EXTERNAL PREPARATION FOR SKIN - An object of the present invention is to provide prevent or improve decreases in the barrier function and moisture retention function of the skin, and that object is achieved by applying an external preparation for skin that comprises a matrix metalloproteinase inhibitor and a heparanase inhibitor. | 12-27-2012 |
20130022693 | PLANT EXTRACTS FOR TREATING NEURODEGENERATIVE DISEASES - The invention relates to the use of bedstraw extracts that can be obtained by means of extracting using water or water-alcohol solvents or mixtures thereof, for producing a formulation, and for treating or preventing neurodegenerative diseases. | 01-24-2013 |
20130236573 | ESKETAMINE FOR THE TREATMENT OF TREATMENT-REFRACTORY OR TREATMENT-RESISTANT DEPRESSION - The present invention is directed to methods for the treatment of treatment-refractory depression or treatment-resistant depression comprising administering to a patient in need thereof, a therapeutically effective amount of esketamine as mono-therapy or as combination therapy with at least on antidepressant. | 09-12-2013 |
20130266671 | Herbal Composition and a Method of Making Thereof - A topical composition is prepared using macerated leaves of St. Andrew's Cross ( | 10-10-2013 |
20130330429 | COMPOSITIONS AND METHODS FOR TREATING DEPRESSION - Disclosed are a novel combination of specific therapeutics selected from S-adenosyl methionine or a salt thereof, folic acid or a metabolite or salt thereof, and one or more omega-3 fatty acids or salts thereof, useful for a variety of conditions, as discussed herein. Methods of treatment include the treatment of neuropsychiatric conditions, such as depression. | 12-12-2013 |
20140093591 | PLANT EXTRACTS FOR TREATING NEURODEGENERATIVE DISEASES - The invention relates to the use of ironwort extracts that can be obtained by means of extracting using water or water-alcohol solvents or mixtures thereof, for producing a formulation, and for treating or preventing neurodegenerative diseases. | 04-03-2014 |
20140093592 | ESKETAMINE FOR THE TREATMENT OF TREATMENT-REFRACTORY OR TREATMENT-RESISTANT DEPRESSION - The present invention is directed to methods for the treatment of treatment-refractory depression or treatment-resistant depression comprising administering to a patient in need thereof, a therapeutically effective amount of esketamine as mono-therapy or as combination therapy with at least on antidepressant. | 04-03-2014 |
20140271945 | IMMUNOASSAY OF S-ADENOSYLMETHIONINE USING ANALOGS THEREOF AND PERSONALIZED THERAPEUTICS - A method of detecting the presence or absence of a disease in a patient wherein said disease is accompanied by deficient levels of S-adenosylmethionine comprising: identifying a patient that is suspected of having said disease or is at risk of having said disease; obtaining a biological sample from said patient; determining the level of S-adenosylmethionine in said biological sample using an antibody derived from a hapten analog of S-adenosylmethionine; and correlating the level of S-adenosylmethionine in said biological sample with the presence or absence of said disease. The invention also provides methods for measuring SAH which is used to determine the methylation index (ratio of SAM/SAH) in biological fluids which is indicative of the health status of an individual. | 09-18-2014 |